Voyageur Pharmaceuticals (CVE:VM) Trading Up 36.8% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price rose 36.8% on Friday . The stock traded as high as C$0.13 and last traded at C$0.13. Approximately 929,313 shares changed hands during mid-day trading, an increase of 383% from the average daily volume of 192,453 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Trading Up 31.6 %

The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business’s fifty day moving average is C$0.07 and its 200 day moving average is C$0.06. The stock has a market cap of C$17.43 million, a PE ratio of -12.50 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.